Navigation Links
Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings
Date:7/18/2008

(CHICAGO) Neurological experts from across the U.S. and other countries including a nationally renowned researcher from Rush University Medical Center will discuss the latest findings in basic and clinical research for Fragile X at the 11th International Fragile X Conference, to be held July 23-27 in St. Louis. Families with children who are diagnosed with Fragile X also will be attending the conference.

Fragile X, an X-chromosome-linked condition, is the most common inherited cause of mental retardation and the most common known cause of autism or autistic-like behaviors.

Rush's Dr. Elizabeth Berry-Kravis, will be leading a number of discussions at the conference including a plenary session on promising new treatments and clinical sessions on stem cell research, seizures and psychopharmacology. In addition, she will be presenting research on the use of lithium to target the underlying defect in Fragile X Syndrome.

Dr. Berry-Kravis runs the only Fragile X clinic in Chicago and one of the few in the Midwest. Her research program also includes studies of fragile X-associated tremor/ataxia syndrome (FXTAS), a degenerative neurological condition which occurs in fragile X mutation carriers, and she will be presenting research on development of new methods for evaluating risk for FXTAS using a state-of-the-art imaging technique called diffusion tensor imaging.

Schedule of scientific and family friendly sessions led by Dr. Berry-Kravis include:

Plenary sessions:

  • New Treatments on the Near Horizon, Thursday, July 24, 9:45 a.m.
  • Seizure Disorders, Saturday, July 26, 2:45 p.m
  • Five Current Topics of Interest in Psychopharmacology of FXS, Saturday, July 26, 11 a.m.

Research abstract presentations:

  • FXTAS (Fragile X-Associated Tremor/Ataxia Syndrome)
    • Diffusion Tensor Imaging in Male FMR1 Premutation Carriers With and Without FXTAS, Wednesday, July 23, 1:30 p.m.
  • Fragile X Syndrome (FXS)
    • Vocabulary Comprehension in FXS, Wednesday, July 23, 4 p.m.
    • ERK Activation Kinetics as a Biomarker for Metabolic Status in FXS, Saturday, July 26, 9:45 a.m.
  • Medications
    • Open Label Treatment Trial of Lithium to Target the Underlying Defect in FXS

    • Fragile X Conference

    • Atypical Autonomic Regulation in FXS: Contrasts with Normal and Effects of Lithium, Saturday, July 26 1:30 p.m.

Scientific-clinical panel sessions:

  • A Conversation with the Experts: Drug Trials and Adults with -Developmental DisabilitiesEthical Issues and Informed Consent, Thursday, July 24, 11 a.m.
  • Stem Cell Research and Its Implications for Fragile X Research and Treatment, Thursday, July 24, 1:30 p.m.

Family-friendly panel sessions:

  • Psychopharmacology Q & A, Sunday, July 29, 9 a.m.
  • Questions, Answers and Difficult Cases: Treatment Issues, Sunday, July 27, 10:30 a.m.


'/>"/>

Contact: Deb Song
deb_song@rush.edu
312-942-0588
Rush University Medical Center
Source:Eurekalert

Related biology news :

1. As rates rise, researchers find better way to identify melanoma
2. Researchers discover a gene that regulates and blocks ovulation
3. Researchers discover link between organ transplantation and increased cancer risk
4. Dartmouth researchers discover gene signatures for scleroderma
5. URI researcher: China cant fully fix air quality problem for Olympics
6. Louisiana Tech researchers feature drug reformulation in prestigious journal
7. UCLA researchers locate and image prostate cancer as it spreads to lymph nodes
8. UCSB researcher leads worldwide study on marine fossil diversity
9. Researchers catch ion channels in their opening act
10. UGA researchers discover mechanism that explains how cancer enzyme winds up on ends of chromosomes
11. Researchers hack final part of the immune system code
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... They call it the ... network, a depiction of a system of linkages and connections so complex and ... professor of computer science at Worcester Polytechnic Institute (WPI) and director of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, will ... analytical testing are being attributed to new regulatory requirements for all new drug ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... ... 11, 2017 , ... A new study published in Fertility ... fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort ... After comparing the results from the fresh and frozen transfer cohorts, the authors ...
Breaking Biology Technology: